Fidexaban

N/A

Report date: 2023/11/30 16:56:40
NME

Base Information

Drug NameFidexaban
Drug Alias Namefidexabanum非地沙班非德沙班ZK-807834BX-807834 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncBayer AG
Active IndicationsN/A
Inactive IndicationsAngina Pectoris

Other Information

ATC CodeN/A
Related LinksKEGG